 |
|
Postexposure Prophylaxis After Nonoccupational HIV Exposure
Clinical, Ethical, and Policy Considerations
Peter Lurie, MD, MPH;
Suellen Miller, CNM, PhD;
Frederick Hecht, MD;
Margaret Chesney, PhD;
Bernard Lo, MD
JAMA. 1998;280:1769-1773.
In the wake of recent breakthroughs in antiviral therapies and Centers for Disease Control and Prevention (CDC) recommendations advocating occupational postexposure prophylaxis (PEP), health care workers are increasingly receiving inquiries about PEP following exposures to the human immunodeficiency virus (HIV) through sex and injection drug use. The probability of HIV transmission by certain sexual or injection drug exposures is of the same order of magnitude as percutaneous occupational exposures for which the CDC recommends PEP. In such cases, if the exposure is sporadic, it seems appropriate to extrapolate from the data on occupational PEP and recommend prophylaxis. However, for individuals with continuing or low-risk exposures, we instead recommend referrals to state-of-the-art risk reduction programs. Clinicians, using local HIV seroprevalence data and their knowledge of transmission probabilities, can help exposed patients make an informed decision regarding PEP. Because of the large number of risky encounters that will not be treated prophylactically, even after significant outreach efforts, public health interventions that emphasize PEP as part of a comprehensive HIV prevention program should be confined to cities with highest HIV prevalences.
From the Center for AIDS Prevention Studies (Drs Lurie, Chesney, and Lo), Department of Medicine, AIDS Program (Dr Hecht), Center for AIDS Research (Dr Chesney), and Division of General Internal Medicine, Program in Medical Ethics (Dr Lo),University of California, San Francisco; Public Citizen's Health Research Group, Washington, DC (Dr Lurie); and the Maternal and Child Health Program, School of Public Health, University of California, Berkeley (Dr Miller).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Postexposure Prophylaxis Following HIV Exposure
M. Anita Barry, James G. Kahn, Steven D. Pinkerton, A. David Paltiel, Peter Lurie, Suellen Miller, Frederick M. Hecht, Margaret Chesney, and Bernard Lo
JAMA. 1999;281(14):1269.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Reducing the Risk of HIV Infection Associated With Illicit Drug Use
Committee on Pediatric AIDS
Pediatrics 2006;117:566-571.
ABSTRACT
| FULL TEXT
Cost-effectiveness of Postexposure Prophylaxis After Sexual or Injection-Drug Exposure to Human Immunodeficiency Virus
Pinkerton et al.
Arch Intern Med 2004;164:46-54.
ABSTRACT
| FULL TEXT
Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus
Havens and Committee on Pediatric AIDS
Pediatrics 2003;111:1475-1489.
ABSTRACT
| FULL TEXT
Infection Control in the ICU
Eggimann and Pittet
Chest 2001;120:2059-2093.
ABSTRACT
| FULL TEXT
Human Immunodeficiency Virus Postexposure Prophylaxis for Adolescents and Children
Merchant and Keshavarz
Pediatrics 2001;108
:e38-e38.
ABSTRACT
| FULL TEXT
Recently diagnosed sexually HIV-infected patients: seroconversion interval, partner notification period and a high yield of HIV diagnoses among partners
European Partner Notification Study Group
QJM 2001;94:379-390.
ABSTRACT
| FULL TEXT
Post-exposure prophylaxis for HIV infection after sexual assault: When is it indicated?
Fong
Emerg. Med. J. 2001;18:242-245.
ABSTRACT
| FULL TEXT
Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2)
Otten et al.
J. Virol. 2000;74:9771-9775.
ABSTRACT
| FULL TEXT
Nonoccupational Postexposure Prophylaxis: Evolving Clinical Practice
AIDS Clin Care 2000;2000:3-3.
FULL TEXT
Postexposure Prophylaxis Following HIV Exposure
Barry et al.
JAMA 1999;281:1269-1269.
FULL TEXT
Antiviral Prophylaxis for Nonoccupational HIV Exposure
JWatch Emergency Med. 1999;1999:12-12.
FULL TEXT
|
